Recently we have seen additional examples of favorable changes in laboratory tests without the expected reduction in risk for tight glucose control for diabetes, fibrate therapy for diabetics, and niacin therapy for patients with heart disease.

FORBES: AstraZeneca Study is Good News for the Public, Bad News for AstraZeneca

"When the medical team ran out of intravenous fluids at the camp, oral glucose-salt packets were used to treat (more than) 3, 000 patients, resulting in a reduction in the mortality rate from 30% to only 3.6%, " the journal said.

CNN: A medical miracle: Saving cholera victims